Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada H2L 4M1.
J Clin Endocrinol Metab. 2012 Mar;97(3):E486-95. doi: 10.1210/jc.2011-1659. Epub 2011 Dec 14.
Congenital isolated ACTH deficiency (IAD) is a rare disease characterized by low plasma ACTH and cortisol levels and preservation of all other pituitary hormones. This condition was poorly defined before we identified TPIT, a T-box transcription factor with a specific role in differentiation of the corticotroph lineage in mice and humans, as its principal molecular cause.
We have enlarged our series of IAD patients to better characterize the phenotype and the genotype of this rare disease.
Each exon of the TPIT gene was amplified and sequenced in IAD patients without any identified cause. A functional analysis of each new TPIT mutation was performed.
We described the largest series of 91 IAD patients and identified three distinct groups: neonatal onset complete or partial IAD or late onset IAD. We did not identify any TPIT mutation in patients with partial or late-onset IAD. However, we found a TPIT mutation in 65% of patients with neonatal-onset complete IAD. These patients are homozygous or compound heterozygous for TPIT mutations, and their parents are healthy heterozygous carriers. We identified nine new mutations: four missense, one one-nucleotide deletion, three splice-site mutations, and one large deletion. TPIT mutations lead to loss of function by different mechanisms, such as non-sense-mediated mRNA decay, abnormal mRNA splicing, loss of TPIT DNA binding or protein-protein interaction defects.
TPIT mutations are responsible for two thirds of neonatal-onset complete IAD but can not be detected in partial or late-onset IAD.
先天性孤立性 ACTH 缺乏症(IAD)是一种罕见疾病,其特征为血浆 ACTH 和皮质醇水平降低,而所有其他垂体激素均正常。在我们发现 TPIT 之前,这种疾病的定义并不明确,TPIT 是一种 T 盒转录因子,在小鼠和人类的促肾上腺皮质激素细胞系分化中具有特定作用,是其主要的分子病因。
我们扩大了 IAD 患者的系列研究,以更好地描述这种罕见疾病的表型和基因型。
在没有明确病因的 IAD 患者中,扩增并测序了 TPIT 基因的每个外显子。对每个新的 TPIT 突变进行了功能分析。
我们描述了最大的 91 例 IAD 患者系列,确定了三个不同的组:新生儿期完全或部分 IAD 或迟发性 IAD。我们在部分或迟发性 IAD 患者中未发现任何 TPIT 突变。然而,我们在 65%的新生儿期完全 IAD 患者中发现了 TPIT 突变。这些患者为 TPIT 突变的纯合子或复合杂合子,其父母为健康的杂合子携带者。我们发现了九个新的突变:四个错义突变,一个单核苷酸缺失,三个剪接位点突变,以及一个大片段缺失。TPIT 突变通过不同的机制导致功能丧失,例如无义介导的 mRNA 衰变、异常 mRNA 剪接、TPIT DNA 结合缺失或蛋白-蛋白相互作用缺陷。
TPIT 突变是导致三分之二新生儿期完全 IAD 的原因,但在部分或迟发性 IAD 中无法检测到。